Skip to main content
SpringerLink
Log in

Kein Nachweis einer Ergebnisverbesserung der Salvage-Radiotherapie beim asymptomatischen biochemischen Prostatakarzinom rezidiv nach Prostatektomie durch additive Androgensuppression

No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Carrie C et al (2016) Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol 17(6):747–756

    Article  CAS  PubMed  Google Scholar 

  2. Dearnaley DP et al (2014) Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol 15(4):464–473

    Article  PubMed  Google Scholar 

  3. Kalbasi A et al (2015) Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer. JAMA Oncol 1(7):897

    Article  PubMed  Google Scholar 

  4. Goenka A et al (2011) Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. Eur Urol 60(6):1142–1148

    Article  PubMed  Google Scholar 

  5. Ost P et al (2011) High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5‑year results. Eur Urol 60(4):842–849

    Article  PubMed  Google Scholar 

  6. Ghadjar P et al (2015) Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. J Clin Oncol 33(35):4158–4166

    Article  CAS  PubMed  Google Scholar 

  7. Zapatero A et al (2015) High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. Lancet Oncol 16(3):320–327

    Article  CAS  PubMed  Google Scholar 

  8. Shipley WU et al (2016) Report of NRG Oncology/RTOG 9601, A phase 3 trial in prostate cancer: Anti-Androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) in patients following Radical Prostatectomy (RP) with pT2-3pN0 disease and an elevated PSA. Int J Radiat Oncol Biol Phys 94(1):3

    Article  Google Scholar 

  9. Duchesne GM et al (2016) Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01–03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet Oncol 17(6):727–737

    Article  CAS  PubMed  Google Scholar 

  10. James ND et al (2016) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 387(10024):1163–1177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Eiber M et al (2015) Evaluation of hybrid (6)(8)Ga-PSMA Ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med 56(5):668–674

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospital Zurich (USZ), Rämistraße 100, 8091, Zurich, Schweiz

    Helena Garcia Schüler &  Matthias Guckenberger

Authors
  1. Helena Garcia Schüler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Guckenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Guckenberger.

Ethics declarations

Interessenkonflikt

H. Garcia Schüler und M. Guckenberger geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Carrie C et al (2016) Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol 17(6):747–756

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garcia Schüler, H., Guckenberger, M. Kein Nachweis einer Ergebnisverbesserung der Salvage-Radiotherapie beim asymptomatischen biochemischen Prostatakarzinom rezidiv nach Prostatektomie durch additive Androgensuppression. Strahlenther Onkol 193, 86–88 (2017). https://doi.org/10.1007/s00066-016-1082-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1082-9

Search

Navigation